期刊文献+

N-糖苷酶基因在脑膜炎败血伊丽莎白金菌临床分离株中的分布 被引量:2

Distribution of N-glycanase genes in clinical isolates of Elizabethkingia meningosepticum
下载PDF
导出
摘要 N‐糖苷酶(PNGase)是真核生物中的常见酶,但在原核生物中极为罕见,目前仅报道在脑膜炎败血伊丽莎白金菌(EM)中存在。本文旨在检测 PNGase基因在EM临床分离株中的分布,为该菌的亚型分类及快速核酸分子检测提供依据,为研究PNGase在原核生物中的生物学功能奠定基础。于2010年7月~2012年12月收集浙江省3家三级甲等医院的65株EM临床分离株,提取细菌基因组 DNA ,利用16 S rRNA细菌通用引物、PNGase F和PNGase F‐Ⅱ特异性引物,进行组合聚合酶链反应(PCR)。阳性扩增产物测序后与美国国立生物技术信息中心(NCBI)数据库中已知EM序列比对确认。结果显示,PNGase阳性菌64株,总阳性率为98.5%;PNGase F和PNGase F‐Ⅱ共阳性菌39株,共阳性率为60.0%。 PNGase F阳性菌41株,阳性率为63.1%;PNGase F‐Ⅱ阳性菌62株,阳性率为95.4%,PNGase F‐Ⅱ阳性率高于 PNGase F (配对χ^2检验, P<0.01),提示 PNGase可能对EM具有重要的生物学意义。结果还表明,本研究建立的组合PCR可应用于E M菌株中 PN G ase基因分型。 The present paper aims to investigate the distribution of two peptide :N‐glycanase (PNGase) genes in Elizabethkingia meningosepticum (EM ) . The genomic DNAs of 65 clinical strains isolated from 3 hospitals in Zhejiang Province were extracted and subjected to polymerase chain reaction (PCR ) for 16 S rRNA , PNGase F and PNGase F‐Ⅱ genes respectively .The PCR products were sequenced and compared to the known sequences in National Center of Biotechnology Information (NCBI) .The results showed that the positive rate of PNGase gene was 98 .5% and the PNGase F/PNGase F‐Ⅱ gene co‐existence rate was 60 .0% .The positive rates of PNGase F gene and PNGase F‐Ⅱ gene were 63 .1% and 95 .4% ,respectively (matching χ^2 test , P〈0 .01) .The results indicate that the developed PCR can be used to detect PNGase gene in EM strains and PNGase activity may be crucial for the survival .
出处 《微生物与感染》 2014年第4期224-229,共6页 Journal of Microbes and Infections
基金 "十二五"国家科技重大专项(2013ZX10004802-002) 宁波市自然基金(2013A610274)
关键词 脑膜炎败血伊丽莎白金菌 聚合酶链反应 N-糖苷酶F-Ⅱ Peptide:N-glycanase F-Ⅱ N-糖苷酶F Elizabethkingia meningosepticum Polymerase chain reaction Peptide:N-glycanase F
  • 相关文献

参考文献23

  • 1Thirumalaikolundusubramanian P. Flavobacterium menin- gosepticum in ICUs [J]. Ann Saudi Med, 1998,18(1): 84.
  • 2Kim KK, Kim MK, Lira JH, Park HY, Lee ST. Transfer of Chryseobacterium meningosepticurn and Chryseobacteri- um miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov [J]. Int J Syst Evol Microbiol, 2005, 55(Pt 3) : 1287-1293.
  • 3Maraki S, Scoulica E, Manoura A, Papageorgiou N, Gian- nakopoulou C, Galanakis E. A Chryseobacterium meningo- septicum colonization outbreak in a neonatal intensive care unit [J]. Eur J Clin Microbiol Infect Dis, 2009, 28 (12): 1415-1419.
  • 4Ceyhan M, Celik M. Elizabethkingia meningosepticum (Chryseobacterium meningosepticum) infections in chil- dren. IntJ Pediatr, 2011, 2011: 215237.
  • 5Lin PY, Chen HL, Huang CT, Su LH, Chiu CH. Biofilm production, use of intravascular indwelling catheters and in- appropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia [J]. Int J Antimicrob Agents, 2010, 36(5): 436-440.
  • 6Hsu MS, Liao CH, Huang YT, Liu CY, Yang CA, Kao KL, Hsueh PR. Clinical features, antimicrobial susceptibili- ties, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medi- cal center in Taiwan, 1999-2006 [J]. Eur J Clin Microbiol Infect Dis, 2011, 30(10) : 1271-1278.
  • 7胡云建.Mohnarin 2006~2007年度报告:非发酵革兰阴性杆菌耐药性监测[J].中国抗生素杂志,2008,33(10):597-601. 被引量:44
  • 8Lin XH, Xu YH, Sun XH, Huang Y, Li JB. Genetic diver- sity analyses of antimierobial resistance genes in clinical Chryseobacterium meningosepticum isolated from Hefei, China [J]. Int J Antimicrob Agents, 2012, 40(2) : 186-188.
  • 9熊旭明,魏衍超,刘卫江,罗辉遇,谢长江,温得良.重症监护病房内脑膜脓毒金黄杆菌医院感染肺炎临床及耐药分析[J].中华医院感染学杂志,2005,15(6):708-710. 被引量:11
  • 10Gosain A, Srivastava A, Saran S. Peptide: N-glycanase is expressed in prestalk cells and plays a role in the differentia- tion of prespore cells during development of Dictyostelium discoideum [J]. Indian J Exp Biol, 2014, 52(3) : 197-206.

二级参考文献21

  • 1汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 2杨启文,王辉,徐英春,谢秀丽,孙宏莉,陈民钧.3种常见非发酵革兰阴性杆菌的体外药物敏感性[J].中国感染与化疗杂志,2007,7(3):198-201. 被引量:14
  • 3汪复.多重耐药铜绿假单胞菌与鲍曼不动杆菌严重感染的防治策略[J].中国感染与化疗杂志,2007,7(3):230-232. 被引量:139
  • 4朱德妹.2005年中国CHINET葡萄球菌属耐药性分析[J].中国感染与化疗杂志,2007,7(4):269-273. 被引量:73
  • 5Nulens E, Bussels B, Bols A, et al. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device[J]. Clin Microbiol Infect,2001,7(7):391-393.
  • 6Gungor S, Ozen M, Akinci A, et al. A Chryseobacterium meningosepticum outbreak in a neonatal ward[J]. Infect Control Hosp Epidemiol, 2003,24(8): 613-617.
  • 7Bloch KC, Nadarajah R, Jacobs R. Chryseobacterlum meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review[J]. Medicine(Baltimore), 1997,76(1):30-41.
  • 8Perera S, Palasuntheram C. Chryseobacterium meningosepticum infections in a dialysis unit[J]. Ceylon Med J, 2004, 49(2):57-60.
  • 9Tekerekoglu MS, Durmaz R, Ayan M, et al. Analysis of an outbreak due to Chryseobacterlum meningoseptlcum in a neonatal intensive care unit[J]. New Microbiol, 2003,26(1): 57-63.
  • 10中华医学会呼吸病学分会.医院内获得性肺感染诊断和治疗指南[J].中华结核和呼吸杂志,1999,22(4):201-201.

共引文献53

同被引文献14

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部